In Diabetes Perspectives, two leading diabetes experts have a taped eye-level discussion on the latest exciting research and clinical initiatives.
The safety of CGM devices cannot currently be guaranteed for people in the European Union, warn Prof. Tadej Battelino...
Guidance documents endorsed by EASD have substantial impact on clinical practice worldwide.
Being active without reaching hypoglycaemia is well possible with current AID technology.
Islet autoantibodies allow us to detect progression to type 1 diabetes early, before the onset of clinical symptoms.